Speaker illustration

Professor Matthew Weir

Baltimore ()

Renin-angiotensin-aldosterone system inhibitor therapy benefit and challenges in cardio-renal patients.

Event: ESC CONGRESS 2017

Topic: Heart failure, other

Session: Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management

Thumbnail

Changing treatment paradigms in the management of chronic hyperkalaemia.

Event: HEART FAILURE 2016

Topic: Chronic heart failure

Session: Hyperkalaemia: are your patients missing out?

Thumbnail

This platform is supported by

logo Novo Nordisk